🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. berotralstat

    Biocryst

    Hereditary Angioedema

    phase 3 small molecule active

    2 trials

  2. bicyclol, 25mg/ tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Drug-Induced Acute Liver Injury

    phase 3 small molecule active

    1 trial

  3. cognitive-behavioral withdrawal regulation strategies

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    phase 3 other active

    1 trial

  4. dactinomycin

    Solid Biosciences

    Sarcoma

    phase 3 mab active

    1 trial

  5. denifanstat

    Sagimet Biosciences

    MASLD

    phase 3 small molecule terminated

    1 trial

  6. diflunisal

    BRIGHT MINDS BIOSCIENCES INC.

    Familial Amyloid Polyneuropathy

    phase 3 small molecule completed

    1 trial

  7. dimethyl fumarate

    Biogen

    Relapsing-Remitting Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  8. eN-Lac®

    Biotech Pharmaceutical Co.,

    Perennial Allergic Rhinitis

    phase 3 mab completed

    1 trial

  9. eRapa (encapsulated rapamycin)

    Biodexa Pharmaceuticals Plc

    Familial Adenomatous Polyposis (FAP)

    phase 3 small molecule active

    1 trial

  10. extended-release naltrexone (XR-NTX)

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine-dependence

    phase 3 small molecule active

    1 trial

  11. filgrastim

    Solid Biosciences

    Ovarian Cancer

    phase 3 mab completed

    1 trial

  12. filgrastim

    Solid Biosciences

    Lymphoma

    phase 3 mab active

    2 trials

  13. filgrastim

    Solid Biosciences

    Lung Cancer

    phase 3 mab active

    1 trial

  14. furmonertinib 240 mg oral, daily

    ArriVent BioPharma

    Metastatic Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  15. gemcitabine

    NORTHWEST BIOTHERAPEUTICS INC

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

  16. gentamicin

    BRIGHT MINDS BIOSCIENCES INC.

    Plague

    phase 3 small molecule completed

    1 trial

  17. granules for suspension, N-Acetyl-L-Leucine

    Intrabio Ireland Limited

    Ataxia Telangiectasia

    phase 3 small molecule active

    1 trial

  18. infigratinib 0.128 mg/kg/day

    BridgeBio Oncology Therapeutics

    Hypochondroplasia

    phase 3 small molecule active

    1 trial

  19. injectable naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 3 small molecule completed

    1 trial

  20. lorcaserin

    BRIGHT MINDS BIOSCIENCES INC.

    Obesity

    phase 3 small molecule terminated

    1 trial

  21. mRNA-1010

    Moderna Biotech Spain

    Seasonal Influenza

    phase 3 mab completed

    1 trial

  22. mRNA-1647, Sodium Chloride 0.9%, Solution for Injection

    Moderna Biotech Spain

    Cytomegalovirus Infection (CMV)

    phase 3 small molecule active

    1 trial

  23. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 3 small molecule completed

    1 trial

  24. naltrexone implant

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources